Abstract
Abstract
Background
Marine sponges and other marine invertebrates are considered hidden treasures for a variety of secondary metabolites with pharmacognostic and pharmacological activities which have the potential to create future “super drugs.”
The main body of the abstract
Dysidea species is one of the most widely distributed sponge species in the world which is found mainly near the shores of the Red Sea, Australia, Yap State, and the Philippines. Dysidea species are considered a source of bioactive natural metabolites that exhibit outstanding chemical diversity. They revealed polybrominated diphenyl ethers, sesquiterpene hydroquinones, furano-sesquiterpenes, diterpenes, chlorinated diketopiperazines, and Amino acids. They showed a broad spectrum of potent biological activities, such as antimicrobial, antimalarial, anti-inflammatory, antitumor, potent cytostatic, antifungal, and antioxidant activities.
Conclusion
This review presents an overview of the isolated secondary metabolites from Dysidea species, and their recorded biological activities covering the published reports in the last 30 years.
Publisher
Springer Science and Business Media LLC
Reference104 articles.
1. Sima P, Vetvicka V (2011) Bioactive substances with anti-neoplastic efficacy from marine invertebrates: Porifera and Coelenterata. World J Clin Oncol 2:355
2. Datta D, Talapatra SN, Swarnakar S (2015) Bioactive compounds from marine invertebrates for potential medicines-an overview. Int Lett Nat Sci 7:42–61
3. Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH (2005) Marine sponges as pharmacy. Mar Biotechnol 7:142–162
4. Badal S, Gallimore W, Huang G, Tzeng T-RJ, Delgoda R (2012) Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata. Org Med Chem Lett 2:21
5. Proksch P, Edrada-Ebel R, Ebel R (2003) Drugs from the sea-opportunities and obstacles. Mar Drugs 1:5–17